Vaxart, Inc.
VXRT
$0.38
$0.00-0.16%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 82.26% | 90.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 82.26% | 90.31% | |||
| Cost of Revenue | 52.70% | 61.77% | |||
| Gross Profit | 64.68% | -1.39% | |||
| SG&A Expenses | -6.98% | -9.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 47.65% | 51.72% | |||
| Operating Income | 46.51% | 2.22% | |||
| Income Before Tax | 45.72% | 3.42% | |||
| Income Tax Expenses | -15.00% | -78.95% | |||
| Earnings from Continuing Operations | 45.68% | 3.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 45.68% | 3.88% | |||
| EBIT | 46.51% | 2.22% | |||
| EBITDA | 53.80% | 2.22% | |||
| EPS Basic | 45.73% | 4.09% | |||
| Normalized Basic EPS | 45.85% | 3.53% | |||
| EPS Diluted | 45.73% | 4.09% | |||
| Normalized Diluted EPS | 45.85% | 3.53% | |||
| Average Basic Shares Outstanding | 0.24% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||